There's a Best Option for Patients With Head-and-Neck Cancer Who Can't Take Cisplatin By Ernie Mundell HealthDay Reporter TUESDAY, Nov. 26, 2024 (HealthDay News) -- Cisplatin is the go-to ...
SEC recommends approval of additional indication for BMS' anti-cancer drug nivolumab: Gireesh Babu, New Delhi Tuesday, November 19, 2024, 08:00 Hrs [IST] The Subject Expert Commit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback